Skip to main content
Lavipharm S.A. logo

Lavipharm S.A. — Investor Relations & Filings

Ticker · LAVI ISIN · GRS246003008 LEI · 213800USC69CRPRGWJ15 AT Manufacturing
Filings indexed 50 across all filing types
Latest filing 2015-09-28 Interim / Quarterly Rep…
Country GR Greece
Listing AT LAVI

About Lavipharm S.A.

https://lavipharm.com/

Lavipharm S.A. is an integrated healthcare company engaged in the research, development, manufacturing, marketing, and distribution of pharmaceutical products. Established in 1911, the company offers a diverse portfolio that includes prescription (Rx) and over-the-counter (OTC) medicines, as well as food supplements. A key area of innovation for the company is its development of transdermal drug delivery systems. Lavipharm focuses on providing treatment options across several major therapeutic areas, including cardiology, neurology (Central Nervous System), urology, oncology, and chronic pain management.

Recent filings

Filing Released Lang Actions
Financial Statement - Full Notes LAVIPHARM S.A. (2007,Six-Month Statement,Company)
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the six-month period ending June 30, 2007, titled 'Financial Statements as of June 30, 2007'. It includes an independent auditor's review report, interim income statement, balance sheet, statement of changes in equity, and cash flow statement. It contains substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). H1 2007
2015-09-28 English
Financial Statement and Information LAVIPHARM S.A. (2008,Three-Month Statement,Both)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Summarised Financial Data and Information' report for the period of January 1, 2008, to March 31, 2008. It contains detailed balance sheet and income statement data for both the consolidated group and the company. Since it covers a quarterly period (Q1 2008) and provides substantive financial statements rather than just an announcement or certification, it is classified as an Interim/Quarterly Report. Q1 2008
2015-09-25 English
Financial Statement and Information LAVIPHARM S.A. (2008,Six-Month Statement,Both)
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements, including a Balance Sheet and Cash Flow Statement for the period ending 30.06.2008, compared against 31.12.2007. It lists board members, auditor information, and financial data for both the consolidated group and the company. Since it provides substantive financial data for a period shorter than a full fiscal year (a half-year report), it is classified as an Interim/Quarterly Report. H1 2008
2015-09-24 English
Financial Statement and Information LAVIPHARM S.A. (2008,Nine-Month Statement,Both)
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements, including a Balance Sheet, Cash Flow Statement, and Income Statement for the period ending September 30, 2008. It provides comparative data for previous periods and is clearly a substantive financial report rather than an announcement or summary. Given it covers a period shorter than a full fiscal year (Q3 2008), it is classified as an Interim/Quarterly Report. 9M 2008
2015-09-24 English
Financial Statement and Information LAVIPHARM S.A. (2010,Year Statement,Both)
Annual Report Classification · 95% confidence The document contains detailed financial statements, including the Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows for the fiscal year ending 31.12.2010. It provides comparative data for 2009 and 2010, lists the Board of Directors, and identifies the auditors. As it contains substantive financial data and analysis for a specific period, it is classified as an Interim/Quarterly or Annual Report. Given the comprehensive nature of the data presented, it fits the definition of an Annual Report (10-K equivalent). FY 2010
2015-09-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.